SMTL ID : 5c02.1

Influenza A M2 transmembrane domain drug-resistant S31N mutant at pH 8.0

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.59 Å

Oligo State

homo-tetramer

Ligands

4 x SR: STRONTIUM ION(Non-functional Binders)

SR.1: 10 residues within 4Å: Chain A: S.2, S.3 Chain B: S.2 Chain C: S.2, S.3 Chain D: S.2, S.3 Ligands: SR.7, SR.13, SR.19 5 PLIP interactions: 1 interactions with chain A, 1 interactions with chain D, 3 Ligand-Water interactions Metal complexes: A:S.2, D:S.2, H2O.1, H2O.2, H2O.3 SR.7: 10 residues within 4Å: Chain A: S.2 Chain B: S.2, S.3 Chain C: S.2, S.3 Chain D: S.2, S.3 Ligands: SR.1, SR.13, SR.19 5 PLIP interactions: 1 interactions with chain C, 1 interactions with chain B, 3 Ligand-Water interactions Metal complexes: C:S.2, B:S.2, H2O.1, H2O.2, H2O.3 SR.13: 10 residues within 4Å: Chain A: S.2, S.3 Chain B: S.2, S.3 Chain C: S.2, S.3 Chain D: S.2 Ligands: SR.1, SR.7, SR.19 5 PLIP interactions: 1 interactions with chain C, 1 interactions with chain A, 3 Ligand-Water interactions Metal complexes: C:S.2, A:S.2, H2O.1, H2O.1, H2O.2 SR.19: 10 residues within 4Å: Chain A: S.2, S.3 Chain B: S.2, S.3 Chain C: S.2 Chain D: S.2, S.3 Ligands: SR.1, SR.7, SR.13 5 PLIP interactions: 1 interactions with chain B, 1 interactions with chain D, 3 Ligand-Water interactions Metal complexes: B:S.2, D:S.2, H2O.1, H2O.1, H2O.3

8 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 11 residues within 4Å: Chain A: S.3, V.7 Chain B: S.3, V.7 Chain C: S.3, V.7 Chain D: S.3, V.7 Ligands: CL.8, CL.14, CL.20 Ligand excluded by PLIP CL.4: 3 residues within 4Å: Ligands: CL.10, CL.16, CL.22 Ligand excluded by PLIP CL.8: 11 residues within 4Å: Chain A: S.3, V.7 Chain B: S.3, V.7 Chain C: S.3, V.7 Chain D: S.3, V.7 Ligands: CL.2, CL.14, CL.20 Ligand excluded by PLIP CL.10: 3 residues within 4Å: Ligands: CL.4, CL.16, CL.22 Ligand excluded by PLIP CL.14: 11 residues within 4Å: Chain A: S.3, V.7 Chain B: S.3, V.7 Chain C: S.3, V.7 Chain D: S.3, V.7 Ligands: CL.2, CL.8, CL.20 Ligand excluded by PLIP CL.16: 3 residues within 4Å: Ligands: CL.4, CL.10, CL.22 Ligand excluded by PLIP CL.20: 11 residues within 4Å: Chain A: S.3, V.7 Chain B: S.3, V.7 Chain C: S.3, V.7 Chain D: S.3, V.7 Ligands: CL.2, CL.8, CL.14 Ligand excluded by PLIP CL.22: 3 residues within 4Å: Ligands: CL.4, CL.10, CL.16 Ligand excluded by PLIP

4 x CA: CALCIUM ION(Non-covalent)

CA.3: 2 residues within 4Å: Chain C: D.4 Ligands: OLC.5 3 PLIP interactions: 1 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:D.4, H2O.1, H2O.1 CA.9: 2 residues within 4Å: Chain D: D.4 Ligands: OLC.11 3 PLIP interactions: 1 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:D.4, H2O.1, H2O.2 CA.15: 2 residues within 4Å: Chain B: D.4 Ligands: OLC.17 3 PLIP interactions: 1 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:D.4, H2O.2, H2O.2 CA.21: 2 residues within 4Å: Chain A: D.4 Ligands: OLC.23 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.4, H2O.3, H2O.3

8 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.5: 11 residues within 4Å: Chain A: V.8, I.12, I.15, L.16, I.19, L.20, L.23 Chain C: D.4, P.5, L.6 Ligands: CA.3 7 PLIP interactions: 1 interactions with chain C, 6 interactions with chain A Hydrophobic interactions: C:L.6, A:I.12, A:I.15, A:L.16, A:I.19, A:I.19, A:L.23 OLC.6: 11 residues within 4Å: Chain A: P.5, V.8, A.9, I.12, I.13, L.16, H.17, L.20 Chain D: L.18, W.21, I.22 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain D Hydrophobic interactions: A:I.13, A:L.16, D:L.18, D:I.22 OLC.11: 11 residues within 4Å: Chain B: V.8, I.12, I.15, L.16, I.19, L.20, L.23 Chain D: D.4, P.5, L.6 Ligands: CA.9 7 PLIP interactions: 6 interactions with chain B, 1 interactions with chain D Hydrophobic interactions: B:I.12, B:I.15, B:L.16, B:I.19, B:I.19, B:L.23, D:L.6 OLC.12: 11 residues within 4Å: Chain B: P.5, V.8, A.9, I.12, I.13, L.16, H.17, L.20 Chain C: L.18, W.21, I.22 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain C Hydrophobic interactions: B:I.13, B:L.16, C:L.18, C:I.22 OLC.17: 11 residues within 4Å: Chain B: D.4, P.5, L.6 Chain C: V.8, I.12, I.15, L.16, I.19, L.20, L.23 Ligands: CA.15 7 PLIP interactions: 6 interactions with chain C, 1 interactions with chain B Hydrophobic interactions: C:I.12, C:I.15, C:L.16, C:I.19, C:I.19, C:L.23, B:L.6 OLC.18: 11 residues within 4Å: Chain A: L.18, W.21, I.22 Chain C: P.5, V.8, A.9, I.12, I.13, L.16, H.17, L.20 4 PLIP interactions: 2 interactions with chain C, 2 interactions with chain A Hydrophobic interactions: C:I.13, C:L.16, A:L.18, A:I.22 OLC.23: 11 residues within 4Å: Chain A: D.4, P.5, L.6 Chain D: V.8, I.12, I.15, L.16, I.19, L.20, L.23 Ligands: CA.21 7 PLIP interactions: 6 interactions with chain D, 1 interactions with chain A Hydrophobic interactions: D:I.12, D:I.15, D:L.16, D:I.19, D:I.19, D:L.23, A:L.6 OLC.24: 11 residues within 4Å: Chain B: L.18, W.21, I.22 Chain D: P.5, V.8, A.9, I.12, I.13, L.16, H.17, L.20 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain D Hydrophobic interactions: B:L.18, B:I.22, D:I.13, D:L.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thomaston, J.L. et al., Crystal structure of the drug-resistant S31N influenza M2 proton channel. Protein Sci. (2016)

Release Date

2016-05-04

Peptides

Matrix protein 2: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Matrix protein 2

Related Entries With Identical Sequence